Ewing’s sarcoma as second malignancy following a short latency in unilateral retinoblastoma
2011

Ewing’s Sarcoma After Retinoblastoma

Sample size: 1 publication Evidence: low

Author Information

Author(s): Tahasildar Naveen, Goni Vijay, Bhagwat Kishan, Tripathy Sujit Kumar, Panda Bijnya Birajita

Primary Institution: Postgraduate Institute of Medical Education and Research, Chandigarh, India

Hypothesis

Can Ewing’s sarcoma develop as a second malignancy in children who have survived unilateral retinoblastoma?

Conclusion

The case highlights that children with unilateral retinoblastoma are at risk of developing second malignancies like Ewing’s sarcoma, which can be effectively treated with aggressive therapy.

Supporting Evidence

  • The cumulative risk of second malignancies in retinoblastoma survivors is 32%.
  • Ninety-eight percent of second malignancies occur in patients with bilateral retinoblastoma.
  • Bone and soft tissue sarcomas are the most common second malignancies.
  • Radiation therapy increases the risk of developing a second malignancy.

Takeaway

A child who had eye cancer developed another type of cancer in his arm later, but doctors were able to help him get better.

Methodology

The child was treated with chemotherapy and radiation therapy after the diagnosis of Ewing’s sarcoma.

Limitations

The study is based on a single case report, limiting generalizability.

Participant Demographics

A 5-year-old boy with a history of unilateral retinoblastoma.

Digital Object Identifier (DOI)

10.1007/s10195-011-0152-0

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication